Jacobson Pharma Corporation Limited (HK:2633) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jacobson Pharma Corporation Limited has announced a positive profit alert, expecting over a 40% increase in profit from continuing operations for the six months ending September 2024. This boost is driven by robust performance in its generic drug sector and successful new product launches. However, a slight decrease in profit attributable to equity shareholders is anticipated due to changes in the consolidation of JBM Healthcare Limited.
For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.